Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01762345 · ClinicalTrials.gov registry record · NA
A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT01762345 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 148 participants.
The verdict
NCT01762345, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
This pilot study will evaluate the efficacy of the pessary (disposable intra-vaginal device) by reduction in urine leakage in women with stress urinary incontinence (SUI).
Interventions
- DEVICE pessary (disposable intra-vaginal device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01762345
The ClinicalTrials.gov registry entry for NCT01762345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pessary (disposable intra-vaginal device) is the first listed.
NCT01762345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01762345 about?
NCT01762345 is a clinical study titled "A Pilot Clinical Study of the Efficacy and Safety of a Disposable Intravaginal Device for Stress Urinary Incontinence". This pilot study will evaluate the efficacy of the pessary (disposable intra-vaginal device) by reduction in urine leakage in women with stress urinary incontinence (SUI).
What is the current status of trial NCT01762345?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2012-12. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01762345?
The interventions under investigation include: pessary (disposable intra-vaginal device) (DEVICE).
Who is sponsoring clinical trial NCT01762345?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.